Credo Diagnostics Biomedical

Credo Diagnostics Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases and animal health. At Credo Diagnostics Biomedical, we are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. We believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management. By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world. For any inquiries, please contact us...

Medical devices,molecular diagnostics,infectious diseases,poct,covid19,rtpcr,pcr,in vitro diagnostics,near patient testing,and point-of-care testing

Credo diagnostics biomedical operates in the Medical equipment manufacturing industry.

Credo diagnostics biomedical's revenue is 11m - 100m

Credo diagnostics biomedical has 11 - 50 employees.